Maintenance therapy of adult acute nonlymphoblastic leukemia.An argument against the need for central nervous system prophylaxis
- 1 February 1978
- Vol. 41 (2) , 697-700
- https://doi.org/10.1002/1097-0142(197802)41:2<697::aid-cncr2820410240>3.0.co;2-m
Abstract
The need for prophylactic therapy of the central nervous system in adult acute nonlymphoblastic leukemia has been suggested but not proven. Over a 4‐year period from January 1973, to December 1976, we have maintained 40 patients achieving complete remission on a regimen consisting of monthly courses of Cytosine Arabinoside and 6‐thioguanine. Twenty patients remain in remission with a predicted median remission duration for the entire group of 14.5 months. Thirty‐nine of the patients did not have central nervous system leukemia at diagnosis, and only one of these patients (2.6%) has had remission terminated by central nervous system relapse. At least with this effective maintenance regimen there is little need for central nervous system prophylaxis in adult acute nonlymphoblastic leukemia.This publication has 13 references indexed in Scilit:
- Radiotherapy in leukemia and lymphoma of childrenCancer, 1977
- Remission maintenance of adult acute lymphoblastic leukemiaMedical and Pediatric Oncology, 1977
- Neurotoxicity Due to CNS Therapy for LeukemiaMedical and Pediatric Oncology, 1977
- Combination chemotherapy of adult acute lymphocytic leukemiaClinical Pharmacology & Therapeutics, 1976
- Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973)Blood, 1975
- Treatment of acute leukemia in adultsCancer, 1975
- Results of Therapy in Adult Acute Lymphocytic LeukemiaOncology, 1975
- Treatment of central nervous system leukemia with intrathecal cytosine arabinosideCancer, 1973
- Clinical pharmacology of l‐β‐D‐arabinofuranosyl cytosineClinical Pharmacology & Therapeutics, 1971
- Meningeal leukemia.A follow-up studyCancer, 1965